Anantha Naik Nagappa

Sponsored Links

Anantha Naik Nagappa's picture
Organization: 
.Manipal University
Job Title: 
Professor
My accomplishments: 
President of Association of community pharmacist of India
Degree(s) awarded: 
B.Pharm, M.Pharm, PhD
College(s) Studied: 
Pharmacy gruop BITS Pilani. Govt college of pharmacy Banglore
Country: 
India
Zip(pin)code: 
576104
Publications: 

Books and Monographs:

* Surface activity in drug action ,R.C.Srivastava and A N Nagappa, Studies in Interface Science, 21 Eds.D. Mobius and R. Miller ,Elsevier Press, North Holand ,2005

      Pharma E-books
        http://www.pharmainfo.net/introduction-autonomic-nervous-system/introduction

      
  

Refereed Journals

Communicated

Effect of losartan potassium with cytochrome P450 enzyme inducer and inhibitor on apomorphine induced stereotypy in mice Pandy VIJAYA PANDI and Anantha Naik NAGAPPA, Biol.Pharm.Bull. (Japan)

In Press

Shivkumar.H, Prakash T,Nagendrarao,R,Jaykumar Swamy, BHM and Nagappa A N,Wound healing activity of the leaves of Thespesia populinaI, Journal of Natural Remedies,2007; 7:120-124

Appeared

International publications:

1. Srikanth B A, Ahmad A, Reddy RK, Balkrishnan R, Nagappa AN. Acceptance of doctor of pharmacy in India: A survey-based study . Arch Pharma Pract 2013;4:93-7.

2. umkur A, Muragundi P M, Shetty R, Naik A. Pharmaceutical care: Need of the hour in India. J Young Pharmacists 2012;4:282-6

3. Abhishek Sharma, Ankush Madaan, Anantha Naik Nagappa. Medication storage and self medication practice among the youth in Karnataka region, India. International Journal of Pharmaceutical Sciences and Research 2012; 3(8):2795-2800

4. Ghalib I. Hundekari*, M.A. Shukoor, A.N. Nagappa, Syeda Shahana and Syeda Saba Antidiabetic Activity Of Parkinsonia Acculeata Linn In Rabbits, Emphasis On C Reactive Protiens. IJPSR, 2012; 3(6): 1721-172.

5. 5Nagappa, AN (2012) Antidiabetic Activity of Parkinsonia Acculeata Linn in Rabbits, Emphasis on c reactive protiens. International Journal of Pharmaceutical Sciences and Research, 3 (6). pp. 1721-1725. ISSN 0975-8232

6. Muragundi, PM and Tumkur, AM and Shetty, RK and Naik, AN Health-related Quality of Life Measurement. Journal of Young Pharmacists 2012, 4 (1). p. 54. ISSN 0975-1483

7. Augustine, Daisy and Naik, Anantha Nagappa and Udupa, N and Balkrishnan, Rajesh Survival outcomes associated with chemotherapy treatment in a cohort of women with breast cancer in Southern India. GSTF Journal of BioSciences(2012), 2 (1). pp. 1-6.

8. A.N. Nagappa, K. Khera, R. Balakrishnan, N.R. Rau, G. Thunga, PMS62 Predictors of Health Related Quality of Life in a Cohort of Patients with Rheumatoid Arthritis in Southern India, Value in Health, Volume 15, Issue 4, June 2012, Page A45, ISSN 1098-3015, 10.1016/j.jval.2012.03.251.

9. A.N. Nagappa, U.V. Mateti, T. Lalwani, V. Bhandary, V. Devaramane, R. Balkrishnan, PMH1 Evaluation of Drug-Related Problems in Depressive Patients, Value in Health, Volume 15, Issue 7, November 2012, Page A669, ISSN 1098-3015, 10.1016/j.jval.2012.08.389.

10. K. Khera, A.N. Nagappa, R. Balakrishnan, S. Sharma, PMS92 Adaptation and Validation of an Indian Version of the Health Related Quality of Life Scale (IND-HAQ) in Indian Patients with Rheumatoid Arthritis, Value in Health, Volume 15, Issue 4, June 2012, Pages A50-A51, ISSN 1098-3015, 10.1016/j.jval.2012.03.281.

11. A.N. Nagappa, P. Gayathri, S. Kachappally, V. Devaramane, V. Bhandary, R. Balkrishnan, PMH78 Retrospective Prescription Analysis of Dementia in a South Indian Psychiatric Hopital, Value in Health, Volume 14, Issue 7, November 2011, Page A301, ISSN 1098-3015, 10.1016/j.jval.2011.08.377.

12. A.N. Nagappa, M. Kumar, S. Noorunnisa, P.V. Bhandary, D. Veerupaksh, R. Balakrishnan, PMH77 Prescription Pattern Evaluation for Bipolar Disorder in a Treatment Facility in India, Value in Health, Volume 14, Issue 7, November 2011, Pages A300-A301, ISSN 1098-3015, 10.1016/j.jval.2011.08.376.

13. . Prasanna R. Deshpande, Kanav Khera, Girish Thunga, Manjunath Hande,1 Siddalingana T. G. Gouda,1 and Anantha Naik Nagappa Atorvastatin-induced acute pancreatitis J Pharmacol Pharmacother. 2011 Jan-Mar; 2(1): 40-42

14. Y.Nayak, V P Veerapur, A N Nagappa and M K Unnikrishnan, Perspectives in Efficacy, Safety and Clinical Evaluation of Bioactive Natural Products,Vol 2 :1-29 ;Comphrehensive Bioactive Natural Products , V K Gupta Ed., Studium Press LLC, U. S.A, 2010

15. Dwibhashyam VS, Keerthi P, Ratna JV, Nagappa AN. Reverse-phase, high performance liquid chromatographic method for the determination of tolterodine tartrate in routine quality control samples.PDA J Pharm Sci Technol. 2009 May-Jun;63(3):234-9.

16. Nagesh C, Venkatesh JS, Shankraiah ., Nagappa AN, Laxmi Narasu and Ramachandra Setty S.Role of liquid membrane phenomena in the biological actions of tinidazole, Pharmacologyonline (2009); 1: 518 - 532

17. Nagappa AN, Sam KG, Zarrin F,Saurabh H Partha G and Pathak K, Evaluation of web sites for quality and contents of Asthma patient Education, J young Pharma,Vol 1 278-283 (2009)

18. Sivagurunathan N, Krishnan S, Rao JV, Nagappa AN, Subrahmanyam VM, Vanathi BM. Synergy of gatifloxacin with cefoperazone and cefoperazone-sulbactam against resistant strains of Pseudomonas aeruginosa. J Med Microbiol. 2008 Dec;57(Pt 12):1514-7.

19. Vijay Pandi, Anantha Naik Nagappa and Prasad A. Thakurdesai , 2007. Effects of Losartan Potassium on Central Dopaminergic System in Mice. Journal of Pharmacology and Toxicology, 2: 551-558.

20. Nagappa AN.,BioBusiness Summit 2005. Global clinical trials in India--prospects and challenges. 14-15 November 2005, New Delhi, India. IDrugs. 2006 Jan;9(1):32-4.

21. A.N. Nagappa, P.L. Kole, D. Srinivas, D. Vivek, D.P. Ullas, R.C. Srivastava, Role of liquid membrane phenomenon in the biological actions of thioridazine, Colloids and Surfaces B: Biointerfaces, Volume 43, Issue 1, 10 June 2005, Pages 21-27, ISSN 0927-7765, 10.1016/j.colsurfb.2005.04.001.

22. R.C.Srivastava and A N Nagappa, Studies in Interface Science ,Surface activity in drug action , , 21 Eds.D. Mobius and R. Miller ,Elsevier Press, North Holand ,2005

23. Sriram D, Yogeeswari P, Nagappa AN., Combinatorial synthesis of anti-HIV agents--a review.Comb Chem High Throughput Screen. 2005 Aug;8(5):377-85.

24. Vijayapandi P, Nagappa AN., Biphasic effects of losartan potassium on immobility in mice.,Yakugaku Zasshi. 2005 Aug;125(8):653-7.

25. Gupta, S. P.; Paleti, Anitha; Mekapati, S. B.; Nagappa, A. N.; Kumaran, S. A Quantitative,Structure-Activity Relationship Study on Some Na+ and K+ Channel Blockers:Role of Molecular Connectivity Index , , Letters in Drug Design and Discovery 2 (2005)pp. 287-290(4)

26. Satya P. Gupta, and Anantha N. Nagappa, Quantitative Structure-Activity Relationship Studies on Cholecystokin Antagonists+ Medicinal Chemistry Reviews - Online, Volume 1, No. 3, 2004

27. P.V. Pandi, P.L. Kole, P.K. Rahul Mishra, I. Shanmukha, K. Girish, A.N. Nagappa, Role of surface activity in the biological actions of ranitidine and famotidine, Colloids and Surfaces B: Biointerfaces, Volume 35, Issues 3-4, 1 June 2004, Pages 243-248, ISSN 0927-7765, 10.1016/j.colsurfb.2004.03.006.

28. A.N. Nagappa, P.L. Kole, P.V. Pandi, K. Zeeyauddin, R.T. Patil, I. Shanmukha, Transport across liquid membranes containing vitamin A (retinol acetate), Journal of Colloid and Interface Science, Volume 271, Issue 2, 15 March 2004, Pages 416-418, ISSN 0021-9797,10.1016/j.jcis.2003.12.014.(http://www.sciencedirect.com/science/article/pii/S0021979703011615)

29. Gupta SP, Nagappa AN.,Design and development of integrase inhibitors as anti-HIV agents.,Curr Med Chem. 2003 Sep;10(18):1779-94. Review.

30. S.P. Gupta, Anoop N. Mathur, A.N. Nagappa, Dalip Kumar, S. Kumaran, A quantitative structure-activity relationship study on a novel class of calcium-entry blockers: 1-[{4-(aminoalkoxy)phenyl}sulphonyl]indolizines, European Journal of Medicinal Chemistry, Volume 38, Issue 10, October 2003, Pages 867-873, ISSN 0223-5234, 10.1016/j.ejmech.2003.08.001.

31. A.N Nagappa, P.L Kole, P.V Pandi, K Girish, P.K Rahul, I Shanmukha, Role of liquid membrane hypothesis in the biological actions of v-blockers, Journal of Membrane Science, Volume 211, Issue 2, 31 January 2003, Pages 349-356, ISSN 0376-7388, 10.1016/S0376-7388(02)00431-3.

32. A.N. Nagappa, P.A. Thakurdesai, N. Venkat Rao, Jiwan Singh, Antidiabetic activity of Terminalia catappa Linn fruits, Journal of Ethnopharmacology, Volume 88, Issue 1, September 2003, Pages 45-50, ISSN 0378-8741, 10.1016/S0378-8741(03)00208-3.

33. A.N Nagappa, P.L Kole, P.V Pandi, I Shanmukha, K Girish, Rahul P.K Mishra, Role of surface activity in mechanism of actions of tricyclic antidepressants, Colloids and Surfaces B: Biointerfaces, Volume 32, Issue 3, 1 November 2003, Pages 169-177, ISSN 0927-7765, 10.1016/S0927-7765(03)00156-5.

34. A.N Nagappa, Binu Cheriyan, Wound healing activity of the aqueous extract of Thespesia populnea fruit, Fitoterapia, Volume 72, Issue 5, June 2001, Pages 503-506, ISSN 0367-326X, 10.1016/S0367-326X(01)00275-1.

35. A Report on India, debate on the validation of traditional medicine, A.N. Nagappa, WHO Essential Drug Monitor No.18 (1994)

36. A.N. Nagappa, D.B. Raju, R.C. Srivastava, Liquid membrane phenomenon in the action of barbiturates, Colloids and Surfaces, Volume 35, Issue 1, 1989, Pages 17-25, ISSN 0166-6622, 10.1016/0166-6622(89)80314-2.

37. R.C Srivastava, G.S.K Velu, A.N Nagappa, D.B Raju, Transport through liquid membrane bilayers generated by prostaglandin E1 in the presence of hydrocortisone, Journal of Colloid and Interface Science, Volume 131, Issue 2, September 1989, Pages 584-587, ISSN 0021-9797, 10.1016/0021-9797(89)90201-4.

38. Gupta SP, Gupta JK, Nagappa AN, Jagannathan V A QSAR study on renin inhibitors., Gangwal D., Drug Des Deliv. 1989 Dec;5(2):73-80.

39. R.C. Srivastava, M. Shankar, A. Tandon, A.N. Nagappa, Liquid membrane phenomena in anticancer drugs. Studies on 5-fluorouracil and its derivatives, International Journal of Pharmaceutics, Volume 38, Issues 1-3, August 1987, Pages 239-245, ISSN 0378-5173, 10.1016/0378-5173(87)90120-7.

40. R.C. Srivastava, A. Tandon, A.N. Nagappa, R.K. Sharma, Liquid membrane phenomena in prostaglandins: Studies on prostaglandin E1 and prostaglandin F2a, Journal of Colloid and Interface Science, Volume 117, Issue 2, June 1987, Pages 375-383, ISSN 0021-9797, 10.1016/0021-9797(87)90396-1.

  1. Tandon, A.N. Nagappa, R.C. Srivastava, Liquid membrane phenomenon in vitamin E: studies on a-tocopherol, International Journal of Pharmaceutics, Volume 32, Issue 1, September 1986, Pages 39-45, ISSN 0378-5173, 10.1016/0378-5173(86)90096-7.
  2. A.N. Nagappa, et al Liquid Membrane Phenomenon in Anti-Cancer drugs, studies on 5- Flurouracil and it's derivatives . Int.J.Pharma., 38, (1987) 239-245
  3. A.N. Nagappa, et al Liquid Membrane Phenomenon in Prostaglandin, studies and Prostaglandin E1, and ProstaglandinF2a, J.Colloids Interface Sri, 17(1987) 375-383
  4. A.N. Nagappa, A, Tandon and R.C Srivastava. Liquid Membrane Phenomenon in Vitamin-E studies on a Tocopherol, Int.J.Pharma, 32, (1986) 39-45.

National publications:

1. Asim Priyendu, Amit Kumar Singh, Anantha Naik Nagappa. Biosimilars: An Offset for Lofty Priced Biologics. The Pharma Review. 2013. September - October; 48-52.

2. Anantha Naik Nagappa, Asim Priyendu, Uday Venkat Mateti. Drug Safety Evaluations- An Elusive

Practice in India. The Pharma Review. 2013. July - August; 69-72.

3. Medikonduri Usha Sree, Lewis Shaila & Anantha Naik N. Applications of Thiolated Chitosans in Drug Delivery. The Pharma Review. 2013. May - June. 65-71.

4. Anantha Naik Nagappa, Asim Priyendu, Uday Venkat Mateti, Swapna S, Vaishnavi Naik. Impact of Compulsory Licensing on Indian Generic Drug Industry. The Pharma Review. 2013. Mar-Apr; 61-64.

5. SwapnaSatheendran, Vaishnavi Naik, Anantha Naik Nagappa. Beginning of The End of The Blockbuster Era. . The Pharma Review. 2012. November-December. 152-164.

6. Vaishnavi Naik, SwapnaSatheendran, Anantha Naik Nagappa. Patient Centered Care New Horizons in Clinical Trials and Drug Development. The Pharma Review. 2012. July - August; 52-64.

7. Anantha Naik Nagappa, Asim Priyendu, Uday Venkat Mateti, Swapna S, Vaishnavi Naik. Impact of Compulsory Licensing on Indian Generic Drug Industry. The Pharma Review. 2013. Mar-Apr; 61-64.

8. Nagappa, AN and Pranov, B and Allani, Pavan Kumar and Sowndarya, P and Nikhil, SB (2012) Evaluation of the quality and contents of obesity patient education on internet. Journal of Pharmaceutical Research, 11 (1). pp. 15-19.

9. Nagappa, Anantha Naik and Joy, Jomy (2012) Perspectives in Regulations of Internet Pharmacy. The Pharma Review. pp. 73-77

10. Vikas, P and Nagappa, Anantha Naik (2012) Medicines for Tomorrow - The Monoclonal Antibodies. The Pharma Review. pp. 48-51.

11. Satheendran, Swapna and Naik, Vaishnavi and Naik, Anantha Nagappa (2012) Beginning of the end of the blockbuster era. The Pharma Review.

12. Indian Journal of Community Medicine/Vol 37/Issue 4/October 2012 264, Prasanna R Deshpande, Anantha N Naik, Chargeless/Free Availability of Medical Literature: The Ethical Need for Development of Global Healthcare (letter to Editor)

13. Venkat, Uday M and Nagesh, A and Thiyagu, R and Rajesh, V and Naik, Nagappa A (2011) Role of community pharmacits in patient's healthcare- a growing need in chronic disease. IJRPC, 1 (3). pp. 470-474

14. Haris, Naila and Bhere, Deepak and Shilpee, * and Piyush, Chaturvedi and Nagappa, Anantha Naik (2011) Metabolomics: Concept, techniques and pharmacological relevance. Journal of Pharmaceutical Research, 10 (2). pp. 60-65.

15. Nagappa, Anantha Naik and Makhija, Inder K and Akunuri, Praneetha and Shripat, Meenakshi (2011) Opportunities and Challenges in Development of Plant Based Therapies. The Pharma Review. pp. 85-91.

16. Venkat , Uday M and Rajesh, V and Laddha, Avinash and Sharma, Shreekant and Nagappa, Anantha Naik (2011) Activities of pharm D students in Indian Hospital. The Pharma Review. pp. 133-134

17. Mateti, Udaya Venkat and Nagappa, Anantha Naik and Patha, Srikala (2011) Clinically relevant drug interactions with newer drugs: A review. The Pharma Review . pp. 71-73.

18. Uday Venkat, M and Nagappa, Anantha Naik (2011) Doctor of pharmacy in India : Scope and professional challenges. Journal of Pharmaceutical Research, 10 (3). pp. 97-101.

19. Nagappa, Anantha Naik and Datta, Vishnu (2011) Biomarkers:Opportunities in Diagnostics and Therapeutics. The Pharma Review . pp. 157-161.

20. Mateti, Uday Venkat and Lalwani, Tarachand and Isukapalli, Sameera and Murgundi, PM and Anantha, NN (2011) E Clinical Trials: Oppurunities and Prospects. The Pharma Review . pp. 89-93.

21. Mateti, Uday V and Sharma, Shreekant and Thiyagu, Rajakannan and Nagappa, Anantha (2011) A critical and comprehensive review on toxicovigilance. Chronicles of Young Scientists, 2 (4). pp. 182-185. ISSN 2229-5186

22. Diasy, PA and Anantha, NN and Shima, RK (2011) Sustainability: A Challenge Ahead for Pharmacy Professionals. The Pharma REview. pp. 73-76.

23. Uday Venkat, M and Naik, Anantha N (2011) Tools For Outcome Research. The Pharma Review, 9 (54). pp. 189-192.

24. A critical and comprehensive review on toxicovigilance Uday V Mateti, Nagesh Adla, Shreekant Sharma, Thiyagu Rajakannan, Anantha N Nagappa Chronicles of Young Scientists, Year 2011, Volume 2, Issue 4 [p. 182-185]

25. Muragundi, PM and Anil, TM and Ranjan, SK and Udupa, N and Anantha, NN (2011) Health Related Quality of Life Instruments. Indian Journal of Pharmacy Practice , 4 (4). pp. 21-28.

26. Nagappa, Anantha Naik and Daisy, PA and Agarwal, Saumya and Kumar, Amit and Virendra, Prasad and Anand, Vivek and Singh, Sukruthi and Bhusare, Kiran (2010) Assessment of Awareness of Disease Knowledge among Health Care and Non Health Care Students. Journal of Pharmaceutical Research, 9 (1). pp. 22-25.

27. Nagappa, Anantha Naik and Kunal, Saxena and Patil, Harshad Ratan (2010) H1N1: Understanding the Enigama. Journal of Pharmaceutical Research, 9 (1).

28. Kadam, Manish S and Nagappa, Anantha Naik and Gnana Sam, Kishore (2010) Recent Advances in Anti Tubercular Drugs. Journal of Pharmaceutical Research, 9 (2).

29. Mukesh, KS and Anil, TM and Daisy, PA and Anantha, NN (2010) Pharmacovigilance and its Impact on Healthcare System in India. The Pharma REview. pp. 64-68.

30. Nagappa, Ananth Naik (2010) Counterfeiting of Pharmaceuticals: Scourage of Modern Health Care and Economy. The Pharma Review . pp. 66-70.

31. Naggappa, Anananth Naik and Narava, Aruna Kumari and Krishna, Murali and Upadhyay, Pooja and Yarlagadda, Soujanya (2010) Export potential of herbal drugs in India. The Pharma Review . pp. 88-92.

32. Saxena, Kunal and Patil, Harshad and Shah, Kushal and Poojee, S and Nagappa, AN (2010) Indian Bayh Dole: Is it Relevant or Negligent? The Pharma Review. pp. 47-51

33. Kunal Saxena, Patil Harshad, Kushal Shah, S Poojee, A N Nagappa Indian Bayh Dole: Is it Relevant or Negligent?,THE PHARMA REVIEW 47-60 (MAR 2010)

34. Anantha Naik Nagappa, Kunal Saxsena, Diasy P. A.THE The Existing Drug Laws and their Enforcement Status; Paradox of Health Care and its Pitfalls ,PHARMA REVIEW 70-74 (NOVEMBER 2009)

35. Nagappa AN, Sam KG, Zarrin F,Saurabh H Partha G and Pathak K, Evaluation of web sites for quality and contents of Asthma patient Education, J young Pharma,Vol 1 278- 283 (2009)

36. Ananthga Naik Nagappa, Rahul N, Anup Naha and Ajay Pise RNAi Emerging Therapies THE PHARMA REVIEW 53-59 (JULY 2009)

37. Kishore Gnana Sam, Modak Raj Sharma, Kafeel Ahmed Khan, Girish Thunga, Padma GM Rao, Ananth Naik Nagappa,Need for Poison Information Centres in India - A Review THE PHARMA REVIEW;37-43 (MARCH 2009)

38. Anantha Naik Nagappa and Devyani Babode Pharmaceutical Nanotechnology, Nano trends,6:1-11,2009

39. Nagappa, Anantha Naik and Rahul, N and Naha, Anup and Pise, Ajay (2009) RNAi Emerging Therapies. The Pharma Review. pp. 53-58.

40. Nagappa, Anantha Naik and Saxsena, Kunal and Diasy, PA (2009) The Existing Drug Laws and their Enforcement Status; Paradox of Health Care and its Pitfalls. The Pharma Review. pp. 70-73

41. The community pharmacist in health care at scotland, Nagappa Anantha NaikNagappa, Vol. 8, No. 4, October 2009

42. Anantha Naik and Srivastava, Namita Kumari and Varghese, Manju and Rupani, Sapna Kamlesh and Poojee, Sudhapalli (2008) Trends in Labeling of Ethical Pharmaceuticals in India. International Journal of Community Pharmacy,, 1 (2). pp. 74-90.

43. Dwibhashyam VS, Nagappa AN. Strategies for enhanced drug delivery to the central nervous system.Indian J Pharm Sci. 2008 Mar-Apr;70(2):145-53.

44. Anantha Naik Nagappa, Kishore G Sam, Manish S Kadam, Kiran M Bhusare, and Pranay Wal, Implementing Patient Safety in Indian Clinical Practice , Pharma Review, XX, 89-96,2008

45. V.S.N.M Dwibhashyam, AN Nagappa Strategies for enhanced drug delivery to the central nervous system, J Pharm Sci 70, 145-153,2008

46. Shivkumar.H, Prakash T,Nagendrarao,R,Jaykumar Swamy, BHM and Nagappa A N,Wound healing activity of the leaves of Thespesia populinaI, Journal of Natural Remedies,2007; 7:120-124

47. Pandi PV, Nagappa AN. Effect of acute and chronic treatment of losartan potassium on tailflick response in mice. Indian J Pharmacol 2006;38:281-282

48. P L Kole, Hemant R Jadhav, P A Thakurdesai and A N Nagappa, Cosmetics: potentials of herbal extracts Natural Products Radiance, 2005 4, 315-321

49. A.N. Nagappa, et al Effect of Ciprofloxacin and norfloxacin liquid membranes on transport of essential ions and nutrients, , Indian J Biochem.Biophys. ,2004,41:48-52

50. A.N. Nagappa, P.V. Pamdi and R.C. Srivastava. Drug-Receptor Intaraction vis-a-vis alternative view of enzyme reactions proposed by Dewar and Storch. J. Surface Science andTechnology,18,(2002) 105-108

51. A.N. Nagappa, et al, Transport Across Liquid Membrane Containing Vitamin D3 (Cholecalciferol), J. Surface Sci. Technol. 18(2002) 1-7.

52. A.N. Nagappa, et al, Transport through liquid membranes containing omeprazole & lansoprazole, Indian J Biochem Biophys 39 (2002) 406-409

53. A.N. Nagappa, et al, Transport through liquid membranes containing Omeprazole and lansoprazole, Ind. J.. Biochem Biophy. Vol. 39, (2002), 406 - 409.

54. A.N. Nagappa, et al, Role of liquid membrane phenomenon in biological actions of ACE inhibitors,Captopril &Lisinopril, Indian J Biochem.Biophys.38 (2001)412-416.

55. Gopkumar P, Shivakumar B, Jayachandran E, Nagappa AN, Nargund LVG, Gurupadaiah , Synthesis and biological activity of 6-fluoro-7-(substituted)-(2-n-p-anilino sulphonamido) benzothiazoles BM INDIAN JOURNAL OF HETEROCYCLIC CHEMISTRY 11 (1): 39-42 JUL-SEP 2001

56. A.N. Nagappa, et al, Role of liquid membrane phenomenon in biological actions of ACE inhibitors, Indian J. Biochem.Biophys, Vol.38,(2001) ,412-416.

57. Synthesis of 8-fluoro-9-substituted (1,3)-benzothiazolo (5,1-b)-1,2,4-triazoles as antimicrobial agents Murthy VS, Nagappa AN, Nargund LVG ,INDIAN JOURNAL OF HETEROCYCLIC CHEMISTRY 8 (1): 23-26 JUL-SEP 1998,

58. Srenivasmurthy, A.N.Nagappa and L.V.G. Nargund, Synthesis of 8 Fluro 9 substituted (1,3) benzthiazole (5,1-6)-1,2,4 triazoles as antimicrobial agents, Indian J. Hetrocyclic Chemistry, Vol. 8(1998) 23-26.

59. Gurupadaiah BM, Jayachandran E, Kumar BS, Nagappa AN, Nargund LVG, Synthesis of Flurobenzo thiazole suphanomide for their Antibacterial activity Indian Journal of Hetrocyclic Chemistry, Vol.7(1998) 213-216

60. Liposomes and it's possible therapeutics applications, A.N Nagappa and N.N Gupta and A.K Sharma, Pharma Today 22. (1995) 9-13.

61. A Policy for quality use of medicine A.N Nagappa and V.G Joshi, PharmaG (1995) 10-12.

62. Pharmaceutical Advertising, a comment on current practices A.N Nagappa, Harikrishna Moran
PharmaG, (1994) 18-21

63. Pharmaceutical Advertising, a comment on current practices A.N Nagappa, Harikrishna Moran PharmaG, (1994) 18-21

64. A Report on India, debate on the validation of traditional medicine, A.N. Nagappa, Essential Drug Monitor No.18 (1994)

65. Retail Pharmacist, a vanishing community, A.N Nagappa, Pharma Times, Vol.26 (1994) 12-15.

66. Nanocapsules an ultrafine targeted drug delivery system. A.N Nagappa, P. Rama Rao Pharma Today 7, (1993) 11-13

67. Q.S.A.R. studies, a rational search for new molecular entities, A.N Nagappa, A.C Bajji, and R.M Joshi PharmaG.5, (1993) 12-30

68. Q.S.A.R. studies, a rational search for new molecular entities, A.N Nagappa, A.C Bajji, and R.M
Joshi PharmaG.5, (1993) 12-30

69. A.N Nagappa and V.G Joshi, Evaluation of Topical preparation Diclofenec sodium, PharmaG, 5,(1993) 31-32.

70. A.N. Nagappa, et al, Liquid Membrane phenomenon in multiple Actions of psychiatric Drugs Indian J.Chem. 31(1992) 533-540

71. A.N. Nagappa, et al, Liquid Membrane Phenomenon in Action of Digitalis, Indian J.Biochem.Biophys. 26,(1991) 73-80.

72. Hypersensitive and Penicillin Allergy, A.N Nagappa and A.D Taranahalli, Pharma Times, 21(1991) 20-28.

73. Dispensing by Medical Practitioner, is it a correct practice? A.N Nagappa and S.R Manavi, Pharma Times, 22(1990) 16-17

74. A.N. Nagappa, D.B.Raju and R.C Srivastava. Liquid Membrane Phenomenon phenomenon in Biological Actions of Prostaglandin F2?, Indian J.Biochem. Biophys., 26(1989)172

75. A.N. Nagappa, et al Liquid Membrane Phenomenon In Biological Actions of Gonadal Steroids Harmones, Indian ,J.Biochem. Biophys., 25, (1988) 350-355

76. Pharmacy as a Health care system Module, A.N Nagappa and G.S.K Velu, Pharma Times, 20(1988) 23-25.

Popular /review articles:

1) Pharmacy as a Health care system Module, A.N Nagappa and G.S.K Velu, Pharma Times, 20(1988) 23-25.

2) Dispensing by Medical Practitioner, is it a correct practice? A.N Nagappa and S.R Manavi, Pharma Times, 22(1990) 16-17

3) Hypersensitive and Penicillin Allergy, A.N Nagappa and A.D Taranahalli, Pharma Times, 21(1991) 20-28.

4) Nanocapsules an ultrafine targeted drug delivery system. A.N Nagappa, P. Rama Rao Pharma Today 7, (1993) 11-13

5) Q.S.A.R. studies, a rational search for new molecular entities, A.N Nagappa, A.C Bajji, and R.M Joshi PharmaG.5, (1993) 12-30

6) Pharmaceutical Advertising, a comment on current practices A.N Nagappa, Harikrishna Moran PharmaG, (1994) 18-21

7) A Report on India, debate on the validation of traditional medicine, A.N. Nagappa, Essential Drug Monitor No.18 (1994)

8) Retail Pharmacist, a vanishing community, A.N Nagappa, Pharma Times, Vol.26 (1994) 12-15.

9) Liposomes and it's possible therapeutics applications, A.N Nagappa and N.N Gupta and A.K Sharma, Pharma Today 22. (1995) 9-13.

10) A Policy for quality use of medicine A.N Nagappa and V.G Joshi, PharmaG (1995) 10-12.

* See Appendix I (www.expresspharmapulse.com; and www.pharmabiz.com) for general articles published.

Appendix I

Publications in Indian express pharma express pulse
1) Bonus offers in Pharmaceutics marketing, A.N Nagappa Giriraj Kulkarni.,

1(1995)-14

2) Pharma Marketing techniques of ethical products, A.N Nagappa S.Vijayendra Swamy, M.Neeraj, and A.Mukane 2(1995) 3.

3) Brand Names Confusing the concerned A.N Nagappa, and R.N Muchery

4) Product manager a new challenge for a young pharmacist A.N Nagappa

T.Giriraj Kulkarni 4(1995) 8

5) Ethics versus Economics. The general medical practitioner and dispensing. A.N Nagappa M.Veena, T.Lakshmi and J.B Indu 5(1995) 8

6) Fixed dose combination-Boon or Bane, A.N Nagappa B.Kalpana M.Smitha

6(1995) 31

7) Barriers in the way of the Pharmacy Profession, A.N Nagappa and M. Venna 7(1995) 31

8) Pharmacist and their role in Health care, A.N Nagappa and V.J Thomas

8 (1995) 21.

9) Cold remedies-Peddelling Placebos, A.N Nagappa and T.Giriraj Kulkarni. 8 (1996) 10.

10) New targets in Anti-HIV therapy, A. N> Nagappa, Kole P. L., 12 (2001),15

Pharmabiz. Com

1) Liver X receptors: New Therapeutic Targets in Atherosclerosis

, Nagappa A N Vijay Pandi P & Ramprasad P R; Wednesday, October 29, 2003 08:00 IST

Project and thesis guided

1) Isolation and characterization of hypoglycemic principles from Eugenia

Jambolana, A.N Nagappa Vikas Chandra and Jagdev Singh Regional

Research Laboratories Jammu Tawi, (1988).

2) Microbial production of oils and fats, A.N Nagappa and P.Somal,

Regional Research Laboratories, Jammu Tawi, (1988).

3) Hepato protective studies of Eclipta-Alba, A.N Nagappa, A.K Singh and

K.K Anand, Regional Research Laboratories, Jammu Tawi (1989).

4) The effect of Hepato protective drug Phylanthus Amarus, on Microsomal Enzymes, A.N Nagappa A.R Shanbagh and A.K Saxena, Regional Regional Research Laboratories Jammu Tawi (1989).

5) Hepato protective activity of medicinal plants, A.N Nagappa M.V Prasad and K.K Anand Regional Research Laboratories Jammu Tawi (1989).

6) Vicine- A comprehensive study of its hypoglycemic and other

Pharmacological activities, P.P subramoni, A.N Nagappa and O.P Gupta

Regional research Laboratories, Jammu Tawi (1989).

7) Modulation of drugs metabolizing enzymes in Albino Rats by piperine,

A.N Nagappa, M.V Aravind and Jaswanth Singh, Regional Research

Laboratories, Jammu Tawi (1989).

8) Plasmid isolation, purification and characterision of gulconobacter oxydans, A.N Nagappa A.P.Koganti, and G.N Qazi, Regional

Research Laboratories, Jammu Tawi, (1989)

9) Report on location, isolation, purification and characterization of stereo

Specific ketoses reductase for Brevin Bacterium, A.N Nagappa

L.Rajendra and G.N Qazi, Regional Research Laboratories, Jammu Tawi.

10) Study state pharmacokinetics of antitubercular formulations, Rajan

Magazine, A.N Nagappa and K.L Bedi, Regional Research Laboratory

Jammu Tawi, (1989).

11) Formulation and evaluation of diclofence sodium topical preparation, A.N Nagappa and V.G Joshi V.L collage of Pharmacy, Raichur (1992).

12) Impact of tropical environment conditions on stability of Atenaol tablets, A.N Nagappa, R.M Joshi, and V Madhusudan, Bapuji Collage of Pharmacy, Davanagere (1994). (MS Pharmacy operations, BITS, Pilani)

13) Screening of leaf extract of Thespesia populnea soland Ex-corr for

wound healing and anti-bacterial activity. A.N Nagappa H Shivkumar

S.C.S Collage of Pharmacy Harapanahalli- (1996)

14) Anti-diabetic activity of D.D.P(multi herbal formulation) in Alloxan

induced Diabetic Albino Rats. A.N Nagappa and C.H Srinivas S.C.S

Collage of Pharmacy Harapanahalli(1996).

15) Hepato protective activity of polyherbal formulation livol and DOMA

Comparative study on CCl4 included Hepato toxicity in albino Rats.

A N Nagappa and R.Venugopal S.C.S Collage of Pharmacy

Harapanahalli (1996)

16) Screening of leaf extract of Mangifera Indica Linn for wound healing

and antimicrobial activity. A.N Nagappa and A.Veeranagouda S.C.S

Collage of Pharmacy Harapanahalli (1996).

17) Preliminary Pharmacological investigations, toxicity studies and

establishment of anti-fertility activity of Jatropa Carcass Limn. A.N

Nagappa and K.P Shivalinge Gowda S.C.S Collage of Pharmacy

Harapanahalli (1997).

18) Pharmacological evaluation of Wrightia tinctoria (Rox B)R. BR,

Screening for its Hepato protective activity. T.S. Abdul Hasseb and

A.N Nagappa S.C.S Collage of pharmacy Harapanahalli (1997).

19) Pharmacological screening of leaf extract of Terminalia catappa Linn.

Studies on antidiabetic activity. A.N Nagappa and Pankaj Gupta S.C.S

Collage of Pharmacy Harapanahalli (1997).

20) Pharmacological evaluation of Spinacis oleraces Linn. Screening for it's Antiulcer activity. A.N Nagappa and Santosh samuel S.C.S Collage of Pharmacy Harapanahalli (1998).

21) Pharmacological screening of leaf extracts prepared from Abutilon

Indicum Linn. A.N Nagappa and V.M Chandershaker S.C.S Collage

Of Pharmacy Harapanahalli (1998).

22) Chermotropism and Pharmacological screening of Cassia tora,

A.N .Nagappa and Dinesh Reddy S.C.S Collage of Pharmacy Harapanahalli

23) Screening of aqueous fruit extract of Thespesia populnea soland Ex-coor for wound healing activity. A.N Nagappa and Binu Cherrian,(2000).

24) Liquid membrane phenomenon in the biological actions of floroquinoline antibacterial agents. A.N.Nagappa and Vijai pandi (2000)

25) Liquid memberane phenomenon in the mechanism of action of Vitamin A and Vitamin D. A.N.Nagappa and K. Zeeyauddin (2000)

26) Role of liquid membrane phenomenon in the actions of ACE inhibitors. A.N.Nagappa and T Rahul patil (2000)

27) Nanocapsules - An ultra fine targeted drug delivery systems. P.Rama Rao and A.N. Nagappa, Pharma Today, 7, 11-113, 1993

Work shops and conferences attended:

1. Computer in Biology National Institute of Immunology, New Delhi,

(1980)

2. Indian Pharmaceutical Congress, Collage of Pharmaceutical Science, Manipal (1980).

3. Indian Pharmacological Congress, Regional Research Laboratory, Hyderbad (1987).

4. International workshop on Pharmacokinetics & Pharmacodynamics of Antibiotics, Astra Zenca Foundation, Banglore (2000).

5. Indian Pharmaceutical Congress, New Dellhi, (2001)

6. International Conference on Surface Science and Technology, (2002).

7. International Symposium on Genomics and Proteomics, BITS, Pilani, 12th - 13th January (2003).

8. International Symposium on Drug Discovery and Process Research, Kolhapur, 23rd - 25th January (2003).

History

Blog
View recent blog entries
Member for
5 years 9 months